![Martin Shkreli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Shkreli
Nessuna posizione attualmente
Profilo
Martin Shkreli founded MSMB Capital Management LLC in 2006, Travere Therapeutics, Inc. in 2008, and Vyera Pharmaceuticals LLC in 2014 where he served as the Chief Executive Officer.
He is also the founder of Phoenixus AG, Gödel Systems, Inc., and Retrophin LLC.
Shkreli held various former jobs including Chairman & Chief Executive Officer at Humanigen, Inc. in 2015, Chief Executive Officer & Director at Desert Gateway, Inc. from 2012 to 2013, and President at Elea Capital Management LLC from 2006 to 2008.
He also worked as an Analyst at Intrepid Capital Management, Inc. (Florida) from 2004 to 2006 and as a Principal at UBS Financial Services, Inc. Shkreli received his undergraduate degree from Baruch College.
Precedenti posizioni note di Martin Shkreli
| Società | Posizione | Fine |
|---|---|---|
| HUMANIGEN, INC. | Amministratore Delegato | 17/12/2015 |
| TRAVERE THERAPEUTICS, INC. | Fondatore | 30/09/2014 |
Retrophin LLC
 Retrophin LLC BiotechnologyHealth Technology Provides biotechnology services | Fondatore | 21/02/2013 |
Desert Gateway, Inc.
 Desert Gateway, Inc. Financial ConglomeratesFinance Operates as a capital pool company | Presidente | 21/02/2013 |
Elea Capital Management LLC
 Elea Capital Management LLC Investment ManagersFinance Elea Capital Management invests in the healthcare sector | Direttore degli Investimenti | 30/05/2008 |
Formazione di Martin Shkreli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
28
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
UBS Financial Services, Inc.
 UBS Financial Services, Inc. Investment ManagersFinance UBS Financial Services' asset allocations are based on a proprietary methodology. In developing those allocations, the firm considers asset class risk and return results that are based on estimated forward-looking return and risk assumptions, as measured by standard deviation, which are based on UBS proprietary research. The development process includes a review of a variety of factors, including the return, risk, correlations and historical performance of various asset classes, inflation and risk premium. | Finance |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Intrepid Capital Management, Inc. (Florida)
 Intrepid Capital Management, Inc. (Florida) Investment ManagersFinance Intrepid Capital is focused on pursuing superior risk-adjusted returns over full market cycles. The firm’s disciplined research process, conservative valuation methodology, and contrarian mindset are the cornerstone of their investment philosophy. Their research is done internally following a bottom-up, value-based strategy. | Finance |
Desert Gateway, Inc.
Desert Gateway, Inc. Financial ConglomeratesFinance Operates as a capital pool company | Finance |
Baruch College
 Baruch College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elea Capital Management LLC
Elea Capital Management LLC Investment ManagersFinance Elea Capital Management invests in the healthcare sector | Finance |
MSMB Capital Management LLC
 MSMB Capital Management LLC Investment ManagersFinance Provides investment advice | Finance |
Retrophin LLC
Retrophin LLC BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Phoenixus AG
 Phoenixus AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on patients with unmet medical needs | Health Technology |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for type 1 diabetes and generic medicines | Health Technology |
Gödel Systems, Inc.
 Gödel Systems, Inc. Packaged SoftwareTechnology Services Operates as software company, which provides data, workflow and communications solutions for financial, law and scientific professionals | Technology Services |
